Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis.

@article{Patten2002HopelessnessRI,
  title={Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis.},
  author={Scott B Patten and Luanne M. Metz},
  journal={International journal of psychiatry in medicine},
  year={2002},
  volume={32 2},
  pages={155-65}
}
OBJECTIVE Two recent randomized double-blind placebo controlled clinical trials of interferon beta-1a in multiple sclerosis have obtained hopelessness ratings using the Beck Hopelessness Scale (BHS). One of these studies, the PRISMS trial, evaluated interferon beta-1a in relapsing remitting multiple sclerosis (RRMS). Another, the SPECTRIMS trial, evaluated the same medication in secondary progressive (SP) MS. The objective of this analysis was to compare levels of hopelessness in persons with… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Depression was strongly associated with hopelessness in both RRMS ( z = 4.13 , p < 0.001 ) and SPMS ( z = 5.24 , p < 0.001 ) .
Two recent randomized double - blind placebo controlled clinical trials of interferon beta-1a in multiple sclerosis have obtained hopelessness ratings using the Beck Hopelessness Scale ( BHS ) .
One of these studies , the PRISMS trial , evaluated interferon beta-1a in relapsing remitting multiple sclerosis ( RRMS ) .
Depression was strongly associated with hopelessness in both RRMS ( z = 4.13 , p < 0.001 ) and SPMS ( z = 5.24 , p < 0.001 ) .
Hopelessness ratings in relapsing - remitting and secondary progressive multiple sclerosis . OBJECTIVE .
All Topics